Jennifer Ahlberg

机构：Boehringer Ingelheim (United States) · ORCID：0000-0002-2892-4163

发表论文 17 篇 · 总被引 455 次 · h-index 10

代表论文

• Selective targeting of the IL23 pathway: Generation and characterization of a novel high-affinity humanized anti-IL23A antibody (2015 · mAbs · 被引 122)
• Generation and functional characterization of anti-human and anti-mouse IL-36R antagonist monoclonal antibodies (2017 · mAbs · 被引 86)
• 5-Aminomethylbenzimidazoles as potent ITK antagonists (2009 · Bioorganic & Medicinal Chemistry Letters · 被引 45)
• VHH antibody targeting the chemokine receptor CX3CR1 inhibits progression of atherosclerosis (2020 · mAbs · 被引 39)
• Maximizing in vivo target clearance by design of pH-dependent target binding antibodies with altered affinity to FcRn (2017 · mAbs · 被引 32)
• GDF11 Treatment Attenuates the Recovery of Skeletal Muscle Function After Injury in Older Rats (2016 · The AAPS Journal · 被引 30)